curdlan has been researched along with lactic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dube, A; Fonteh, P; Hayeshi, R; Khumalo, V; Labuschagne, P; Lubuschagne, P; Madziva, MT; Meyer, D; Naicker, B; Ndamase, A; Swai, H; Tukulula, M | 1 |
| Dube, A; Fonteh, P; Hayeshi, R; Khumalo, V; Labuschagne, P; Madziva, MT; Meyer, D; Naicker, B; Ndamase, A; Swai, H; Tukulula, M | 1 |
| Bekale, RB; D'Souza, S; Du Plessis, SM; Dube, A; Egieyeh, S; Irabin, AF; Maphasa, RE; Sampson, SL | 1 |
3 other study(ies) available for curdlan and lactic acid
| Article | Year |
|---|---|
Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities.
Topics: Antitubercular Agents; beta-Glucans; Biological Transport, Active; Caco-2 Cells; Carbohydrate Sequence; Cell Membrane Permeability; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Humans; Intestinal Absorption; Lactic Acid; Macrophages; Molecular Sequence Data; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Stimulation, Chemical | 2015 |
Erratum to: Curdlan-conjugated PLGA Nanoparticles possess macrophage stimulant activity and drug delivery capabilities.
Topics: beta-Glucans; Caco-2 Cells; Cell Line, Tumor; Drug Delivery Systems; Humans; Lactic Acid; Macrophages; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis.
Topics: beta-Glucans; Drug Carriers; Glycols; Lactic Acid; Mycobacterium tuberculosis; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |